levofloxacin has been researched along with agar in 9 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (agar) | Trials (agar) | Recent Studies (post-2010) (agar) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 10,357 | 38 | 1,953 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ballone, E; Catamo, G; D'Antonio, D; Di Bonaventura, G; Piccolomini, R | 1 |
| Desmond, EP; Nieda, RR; Sanders, CA | 1 |
| Arsenault, I; Danion, A; Vermette, P | 1 |
| Agejeva, A; Altraja, A; Klaos, K; Kummik, T; Laks, S; Remets, O; Sasi, S; Tann, A; Viiklepp, P | 1 |
| Hitomi, S; Kikuchi, N; Nemoto, D | 1 |
| Chang, YT; Chen, TC; Huang, HY; Lin, SY; Lu, PL; Wang, YL; Wu, JH; Yang, TY | 1 |
| Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A | 1 |
| Khan, M; Ma, K; Wan, I; Willcox, MD | 1 |
| Nakaminami, H; Tanaka, E; Uchiya, KI; Wajima, T | 1 |
9 other study(ies) available for levofloxacin and agar
| Article | Year |
|---|---|
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients.
Topics: Agar; Anti-Infective Agents; Culture Media; Diffusion; Drug Resistance, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Ofloxacin; Staphylococcus | 2002 |
Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Culture Media; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 2004 |
Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin.
Topics: Agar; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colony Count, Microbial; Contact Lenses; Culture Media; Kinetics; Levofloxacin; Liposomes; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Surface Properties | 2007 |
A successful introduction to a non-expert setting of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosis.
Topics: Agar; Antitubercular Agents; Color; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Observer Variation; Rifampin; Sensitivity and Specificity | 2021 |
Periprosthetic knee joint infection caused by Sneathia sanguinegens.
Topics: Agar; Anti-Bacterial Agents; Arthritis, Infectious; Carbon Dioxide; Cefepime; Female; Fusobacteria; Gram-Negative Bacteria; Humans; Knee Joint; Levofloxacin; Prosthesis-Related Infections | 2022 |
Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.
Topics: Agar; Anti-Bacterial Agents; Bacteremia; Humans; Levofloxacin; Microbial Sensitivity Tests | 2022 |
Genotypic Detection of
Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Topics: Agar; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Gentamicins; Humans; Imipenem; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus revealed through a horizontal transfer assay using Haemophilus influenzae.
Topics: Agar; Amino Acid Substitution; Anti-Bacterial Agents; Child; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Quinolones | 2023 |